Compass Therapeutics
CMPX · NASDAQ
$0.8333−$0.0017 (−0.20%)TodayMarket closed ·
Prev close $0.835
Who owns CMPX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 57.1% of CMPX’s shares.
- Tang Capital Management, LLC10.0%
- OrbiMed Advisors, LLC8.5%
- Montanova Capital, LLC7.8%
- BlackRock Institutional Trust Company, N.A.5.7%
- Next 6 largest institutions25.2%
- All other shareholders42.9%
| Holder | Shares | % of shares |
|---|---|---|
| Tang Capital Management, LLC | 17.99M | 9.99% |
| OrbiMed Advisors, LLC | 15.22M | 8.45% |
| Montanova Capital, LLC | 14.10M | 7.83% |
| BlackRock Institutional Trust Company, N.A. | 10.24M | 5.68% |
| State Street Investment Management (US) | 9.95M | 5.53% |
| Enavate Sciences GP, LLC | 7.79M | 4.32% |
| Boylan (James P.) | 7.79M | 4.32% |
| Vivo Capital, LLC | 7.76M | 4.31% |
| Vanguard Capital Management, LLC | 6.12M | 3.40% |
| Schuetz (Thomas J.) | 5.91M | 3.28% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| State Street SPDR S&P Biotech ETF | 7.22M | 4.01% |
| Vanguard Total Stock Market Index Fund | 4.19M | 2.33% |
| iShares Russell 2000 ETF | 3.44M | 1.91% |
| Vanguard Extended Market Index Fund | 1.80M | 1.00% |
| Fidelity Enhanced Small Cap Core ETF | 1.56M | 0.86% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $21.25K (2 trades) of CMPX on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Lerner Neil | Buy | 20.00K | $18.40K |
| Lerner Neil | Buy | 2.50K | $2.85K |
| Anderman Jonathan | Award | 25.00K | $47.25K |
| Lerner Neil | Award | 15.00K | $28.35K |
Short interest
Settled Sep 30, 2026
- Shares short
- 40.36M
- Days to cover
- 6.26
- % of shares outstanding
- 22.41%
- Average daily volume
- 6.45M
- Change since last report
- −3.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.